Skip to main content

Table 1 Base Analysis results

From: Cost-effectiveness of different treat-to-target strategies in rheumatoid arthritis: results from the DREAM registry

  Step-up Initial Combination
Mean costs (€) 25,377.01 20,856.56
Mean utility (QALY) 3.501 3.545
ICER −139,000 (Dominating)